Liver disease is a grave, silent ailment affecting millions of individuals worldwide. While various tests are available to detect liver disease, the dependability and precision of these tests can differ significantly.
A new test known as Fibroscan has been developed to address this issue, providing a dependable and accurate way of diagnosing and monitoring liver disease.
What is Fibroscan?
Fibroscan is a non-invasive diagnostic tool that utilizes ultrasound waves to measure the firmness of the liver. A small gadget is positioned on the skin, which transmits energy pulse into the liver.
The velocity at which the pulse travels through the liver is measured by the device, indicating the stiffness of the liver. The results are then examined to determine the severity of liver damage.
Fibroscan versus Other Liver Tests
Unlike other tests, such as blood tests or liver biopsies, Fibroscan is non-invasive and does not require needles or surgery. As a result, it is a more comfortable and convenient alternative for those with liver disease.
Furthermore, Fibroscan is more dependable and precise than some other tests, with studies indicating that it has a high level of sensitivity and specificity.
The Importance of Fibroscan for People with Liver Disease
Fibroscan is essential for those suffering from liver diseases like NASH/ NAFLD/ Fatty Liver since it can aid in early detection. Early detection is vital for effectively treating and managing liver disease since it can prevent further liver damage and reduce the risk of complications.
Furthermore, Fibroscan can be used to monitor the progression of liver disease and treatment efficacy.
Real-life Data on the Effectiveness of Fibroscan
Real-world data has shown that Fibroscan is highly effective in diagnosing and monitoring liver diseases like NASH, NAFLD or Fatty Liver. By a recent study, Fibroscan has an 81% sensitivity and an 84% specificity in detecting liver fibrosis.
This makes it a highly dependable tool for detecting and monitoring liver disease. Fibroscan is also more accurate than some other liver tests.
Enrolling in Clinical Trials on Fibroscan
Om Research is conducting NASH/ NAFLD/ Fatty Liver Disease clinical trials using Fibroscan as one of the tests to evaluate the safety and effectiveness of potential treatments. Clinical trials are an important part of medical research since they help assess the safety and effectiveness of new medical treatments and technologies.
By participating in our clinical trials, you can assist in advancing medical research and contribute to the development of new treatments for liver diseases like NASH, NAFLD or Fatty Liver.
Conclusion
Fibroscan is a revolutionary diagnostic tool that provides a dependable and accurate, non-invasive way to diagnose and monitor liver disease. If you have been diagnosed with liver disease or are at risk of developing NASH, NAFLD or Fatty liver disease because of diabetes, obesity, high cholesterol, or high blood pressure, Fibroscan is a crucial tool that can help ensure early detection.
Furthermore, by enrolling in our clinical trials using Fibroscan, you can contribute to advancing medical research and aid in the development of new treatments for liver disease.
Contact Om Research at (855) 75-TRIALS or via email at info@omclinicaltrials.com or visit our website omclinicaltrials.com to learn more about our NASH, NAFLD, or Fatty Liver clinical trials and how you can get a free Fibroscan at no cost to you nor your insurance.
